Investing.com - Selecta Bio (NASDAQ: SELB) reported first quarter EPS of $-0.140, $0.05 worse than the analyst estimate of $-0.087. Revenue for the quarter came in at $5.94M versus the consensus estimate of $11.62M.
Selecta Bio's stock price closed at $1.150. It is down -37.500% in the last 3 months and up 35.190% in the last 12 months.
Selecta Bio saw 2 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Selecta Bio's stock price’s past reactions to earnings here.
According to InvestingPro, Selecta Bio's Financial Health score is "great performance".
Check out Selecta Bio's recent earnings performance, and Selecta Bio's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar